好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Leveraging EEG Foundation Models for Data-efficient and Clinically Robust Neurological Diagnostics
Epilepsy/Clinical Neurophysiology (EEG)
P7 - Poster Session 7 (8:00 AM-9:00 AM)
10-002

In this work, we present a comprehensive research program leveraging EEG foundation models to unlock the development of new EEG-based biomarkers for neurological pathologies.

Applications derived from artificial intelligence (AI) models in EEG are limited to date due to the complexity of the EEG signal and the small volumes of accessible annotated data, incompatible with the needs of deep learning. 
In order to unlock this AI limitation, we developed self-supervised EEG foundation models for clinical applications. The models combine spectral tokenization with masked token prediction to learn generalizable spatiotemporal patterns from large volumes of unlabeled EEG data. The model's ability to improve the performance of AI algorithms on various EEG use cases has been tested on numerous downstream tasks.
Our model was evaluated on three diagnostic tasks: 

- Seizure detection on public Temple University EEG Seizure database (TUSZ) (n=7,152 windows)
- Normal/abnormal classification on both proprietary data (n=15,285), and public Temple University Abnormal (TUAB) database (n=23,040),
- Multiclass pathology differentiation on proprietary data (n=15,285) with 4 labels ( Normal/Lesion/Status Epilepticus/Encephalopathy). 

On seizure detection task, the model achieved an AUROC at 0.926 ± 0.002 with a sensitivity at 0.909 ± 0.035. For normal/abnormal classification, the AUROC reached 0.970 ± 0.001 on proprietary database and 0.910 ± 0.002 for the public one. Finally, the multiclass pathology differentiation obtained a Weighted F1 at 0.730 ± 0.001. On these tasks our model achieved or surpassed state-of-the-art results. 

Importantly, in low-data regimes (<10% of available data), the model improved AUPRC by 2–17%, demonstrating strong data efficiency. 

Ongoing work focuses on leveraging EEG foundation models as a universal backbone for diverse EEG diagnostic applications, including abnormality subtype classification, seizure event identification, etc.... Our findings demonstrate that foundation models can catalyze the development of versatile, resource-efficient, and clinically relevant EEG analysis systems, paving the way toward scalable AI-assisted neurology. 

Authors/Disclosures
Ruggero G. Bettinardi, PhD
PRESENTER
Mr. Bettinardi has received personal compensation for serving as an employee of BIOSerenity.
Ulysse Gimenez, PhD Dr. Gimenez has nothing to disclose.
Mohamed Rahmouni Mr. Rahmouni has received personal compensation for serving as an employee of Bioserenity Medical Devices Group.
Aurore Bussalb, PhD Dr. Bussalb has received personal compensation for serving as an employee of Bioserenity.
Priscille de Dumast, PhD Dr. de Dumast has nothing to disclose.
Antoine Honoré, PhD Mr. Honoré has received personal compensation for serving as an employee of Bioserenity. Mr. Honoré has received personal compensation for serving as an employee of KTH Royal institute of Tehnology.
Camille Lamy, Engineer Mr. Lamy has received personal compensation for serving as an employee of Bioserenity.
Hugo Launay, PhD Dr. Launay has nothing to disclose.
FRANCOIS LE GAC Mr. LE GAC has received personal compensation for serving as an employee of BIOSERENITY.
Guillaume JUBIEN Mr. JUBIEN has received personal compensation for serving as an employee of BIOSerenity.
Pierre EMERICH Mr. EMERICH has nothing to disclose.